Inicio › Cáncer metastásico › Misuri › Kansas City
Ensayos clínicos de Cáncer metastásico en Kansas City, MO
15 estudios para Cáncer metastásico buscan participantes en centros de Kansas City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ReclutandoFase 1
- St. Lukes Hospital of Kansas City, Kansas City
A Study of ASP3082 in Adults With Advanced Solid Tumors
ReclutandoFase 1
- University of Kansas Medical Center, Westwood · A 5 mi de distancia
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
ReclutandoFase 1
- University of Kansas Hospital-Westwood Cancer Center, Westwood · A 5 mi de distancia
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- University of Kansas Medical Center, Westwood · A 5 mi de distancia
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- Premier Imaging, Kansas City
- St. Joseph Medical Center, Kansas City
- MidAmerica Cancer Care - American Oncology Partners, Kansas City
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
ReclutandoFase 1
- The University of Kansas Medical Center, Westwood · A 5 mi de distancia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Saint Luke's Cancer Institute, Kansas City
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- The University of Kansas Cancer Center - Westwood, Westwood · A 5 mi de distancia
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
ReclutandoFase 1/2
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · A 5 mi de distancia
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ReclutandoFase 3
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center, Westwood · A 5 mi de distancia
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
ReclutandoFase 3
- Saint Luke's Cancer Institute, Kansas City
- The University of Kansas Cancer Center, Westwood · A 5 mi de distancia
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
ReclutandoFase 2/3
- MidAmerica Cancer Care, Kansas City
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
ReclutandoFase 3
- University of Kansas Cancer Center, Westwood · A 5 mi de distancia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Kansas City
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Kansas City
- Cáncer de seno34 estudios
- Cáncer de pulmón de células no pequeñas31 estudios
- Fallo cardíaco25 estudios
- Cáncer (todos los tipos)21 estudios
- Cáncer de pulmón19 estudios
- Cáncer del colon y del recto16 estudios
- Leucemia mielógena aguda15 estudios
- Cáncer de próstata14 estudios
- Cáncer de ovario11 estudios
- Obesidad11 estudios
- Diabetes tipo 211 estudios
- Enfermedad cardiovascular11 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.